UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare Pediatric ...

Building on its reputation for fostering breakthrough approaches to precision medicine, the 24th annual Bio-IT World Conference & Expo, April 2-4 in Boston, will feature a plenary keynote program of ...

Q4 2024 Earnings Call Transcript March 12, 2025 Amarin Corporation plc beats earnings expectations. Reported EPS is $-0.03, ...

Helix, a leader in population genomics and precision health, will unveil new clinical research from the Helix Research Network TM (HRN) and its partners at the 2025 ACMG Annual Clinical Genetics ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...